The concentration of three anti-seizure medications in hair: The effects of hair color, controlling for dose and age

BMC Clinical Pharmacology

Volumn 1, Issue , 2001, Pages

  Mieczkowski, Tom ^a   Tsatsakis, Aristidis M ^b   Kruger, Michael ^c   Psillakis, Thanasis ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF CRETE   (Greece)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; PHENYTOIN; VALPROIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; COVARIANCE; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG HAIR LEVEL; FEMALE; GROUPS BY AGE; HAIR ANALYSIS; HAIR COLOR; HUMAN; HUMAN TISSUE; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; SEIZURE; STATISTICAL MODEL;

AGE FACTORS; ANTICONVULSANTS; CARBAMAZEPINE; HAIR; HAIR COLOR; HUMANS; PHENYTOIN; VALPROIC ACID;

EID: 0242433903     PISSN: 14726904     EISSN: 14726904     Source Type: Journal    
DOI: 10.1186/1472-6904-1-2     Document Type: Article

References (32)

1. Baumgartner WA, et al: Detection of drug use by (RIA) of hair. Clin Nucl Med 1985, 10:A3-
2. Schutz H, et al: The detection of drugs and other foreign substances in hair. Pharm Unserer Zeit 1993, 22:65-78
3. Chatt A, Katz S: Hair Analysis: Applications in the Biomedical and Environmental Sciences. New York: VCH Publishers, 1988,
4. Arnold W: RIA analysis of head hair for narcotics and substitutes. J Clin Chem Clin Biochem 1986, 24:797-
5. Koren G: Hair tests to verify gestational cocaine exposure. In: Sunshine, I. ed. Recent Developments in Therapeutic Drug Monitoring in Clinical Toxicology, New York : Marcel Dekker, 1992, :569-573
6. Mieczkowski T: New approaches in drug testing: A review of hair analysis. Ann Am Acad Pol & Soc Sci 1992, 521:132-150
7. Kintz P, et al: Evaluation of nicotine and cotinine in human hair. J Forensic Sci 1992, 37:72-76
8. Balabanova S, et al: Detection of caffeine in human hair by EIA and GC/MS Proceedings. Scientific Symposium Rechtsmedizin und Forensiche Toxikologie, Hamburg, 1990, :118-126
9. Sato R, et al: Human scalp hair as evidence of individual dosage history of haloperidol: Prospective study. Ther Drug Monit 1989, 11:686-691
10. Matsuno H, et al: The measurement of haloperidol and reduced haloperidol in hair as an index of dosage history. Br J Clin Pharmacol 1990, 29:187-194
11. Runne U, et al: Sequential concentration of chloroquine in human hair correlates with ingested dose and duration of therapy. Acta Dermato-Venereolog 1992, 72:355-357
12. Tracqui A, et al: Determination of amitriptyline in the hair of psychiatric patients. Hum Exp Tox 1992, 11:363-367
13. Miyazawa N, et al: Ofloxacin in human hair determined by HPLC. Forensic Sci Int 1991, 51:65-77
14. Uematsu T: Possible effect of pigment on the pharmacokinetics of ofloxacin and its excretion in hair. J Pharmaceut Sci 1992, 81:45-48
15. Uematsu T: The measurement of a new antimicrobial quinolone in hair as an index of drug exposure. Br J Clin Pharmacol 1993, 35:199-203
16. Mizuno A, et al: Simultaneous determination of ofloxacin, norfloxacin and ciprofloxacin in human hair by HPLC and fluorescence detection. J Chromatogr B 1994, 653:187-193
17. Cirimele V, et al: Evidence of pesticide exposure by hair analysis. Acta Clinica Belgica 1999, 1:59-73
18. Deveaux M, et al: Immunoassay of digoxin in hair. p. 219-223. For Sci Int 1997, 84:1-3
19. Wheeler MJ, et al: The measurement of testosterone in hair. J Endocrinol 1998, 159:5-8
20. Deng , et al: Detection of anabolic steroids in hair J. Forensic Sci 1999, 44:343-346
21. Williams J: Sectional hair analysis as a potential index of therapeutic compliance in an epileptic population In: deZeeuw, R., Munthiri, S., el Hosani, B. eds. Proceedings of the International Conference and Workshop for Hair Analysis in Forensic Toxicology, Abu Dhabi, UAE 1995, :443-466
22. Williams J: The assessment of therapeutic compliance based on the analysis of drug concentrations in hair. In: Mieczkowski, T. ed. Drug Testing Technology-Assessment of Field Applications, Boca Raton, Florida, CRC Press, 1999, :1-32
23. Kintz P, et al: Testing hair for carbamazepine in epileptic patients: Is hair investigation suitable for drug monitoring? Human Exper Toxicol 1995, 14:812-815
24. Mei Z: Simultaneous determination of phenytoin and carbamazepine in human hair by HPLC. Ther Drug Monit 1997, 1:92-94
25. Saris L: HPLC determination of carbamazepine and metabolites in human hair. J Chromatogr B Biomed Appi 1997, 691:409-415
26. Tsatsakis AM, et al: Carbamazepine levels in the hair of patients under long-term treatment: a preliminary study. Clinica Chimica Acta 1997, 263:187-195
27. Tsatsakis AM, et al: Determination of phenytoin in sections of head hair: a preliminary study to evaluate the history of drug use. Bolletino Chimico Farmaceutico 1998, 137:459-466
28. Psillakis T, et al: Carbamazepine levels in head hair of patients under long-term treatment: A method to evaluate the history of drug use. J Clin Pharmacol 1999, 39:55-67
29. Tsatsakis AM, Psilakis TK, Alegakis Th.K, Tzatzarakis M: Determination of carbamazepine and valproic acid in human head hair. in: 34th Intern. Proceedings, Congress Forensic Toxicology, TIAFT, Interaken, Switzerland 1996, :43
30. Tracqui A, Kintz P, Mangin P: Hair analysis: A worthless tool for therapeutic compliance monitoring. For. Sci Int 1995, 70[1-3]:183-189
31. Mieczkowski T: Drug Testing Technology. Assessment of Field Applications, Boca Raton, Florida, CRC Press, 1999,
32. Mieczkowski T: Is a color effect demonstrated for hair analysis of carbamazepine? Life Sci 2000, 671:39-43